Actively Recruiting
Prospective Data Collection on Patients Receiving Autologous or Allogeneic Hematopoietic Stem Cell Transplants for Blood and Immune Diseases
Led by Wake Forest University Health Sciences · Updated on 2026-04-13
2000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting and analyzing data from people undergoing either autologous or allogeneic hematopoietic stem cell transplants or cellular therapies for various diseases where no specific research question is currently being addressed. This observational study aims to gather information on treatments that have already shown efficacy in published studies. It also allows for the retrospective study of cellular products when there is a defined research question. Participants receive standard preparative regimens as part of their bone marrow transplant or cellular therapy procedures. The study does not involve experimental treatments but focuses on gathering data prospectively as patients undergo these approved therapies. Consent is also sought for future retrospective analysis of cellular products if applicable. During the study, researchers will follow participants for one year to collect follow-up data, tracking outcomes and safety information. Participants medical records and data will be stored and reported according to approved protocols. The study is observational, with no intervention assigned by the research team, and participation may last up to a year for data collection purposes.
CONDITIONS
Brief Title
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Research Team
D
Dianna Howard, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here